Small molecules targeting PSMA, such as PSMA-617 and PSMA-I&T, have a larger permeability in solid tumors and a faster blood clearance, which leads to higher tumor uptake and higher specific binding to PSMA receptors [11]. Here, FOLH1 is linked to neoplasm.